This case study discusses a patient initially diagnosed with high-risk prostate cancer who underwent androgen deprivation therapy. The patient subsequently presented with ductal carcinomain situ and was found to be a BRCA2mutation carrier with a strong family history of breast cancer.
- Seema Panchal
- Orli Shachar
- Louise Bordeleau